From Lab Through Launch

From early formulation through global commercial launch, this late-stage promotional video highlights what it takes to deliver complex injectable therapies with confidence. Decades of sterile injectables expertise underpin an integrated CDMO approach designed to reduce risk, eliminate disruptive handoffs, and preserve critical product knowledge across the lifecycle. Multidisciplinary teams work in lockstep to keep programs on track and timelines moving—whether supporting biologics, including antibody-drug conjugates, cytotoxics, highly potent compounds, or small-molecule drugs.

Deep experience in lyophilization development and optimization strengthens product robustness, while redundant capacity and significant ongoing investments help ensure a reliable, resilient supply. The focus is not only on manufacturing at scale, but on seamless execution — connecting development, clinical supply, and commercial production into a single, coordinated pathway. The result is a partnership built to accelerate progress, safeguard quality, and support informed decision-making at every step. Watch the full video to see how integrated expertise and long-standing technical depth come together to support successful launches in today’s demanding injectable landscape.